TCL Archive Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer December 27, 2002
TCL Archive FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer February 21, 2003
TCL Archive A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies October 2, 2009